FOOTHILL RANCH, Calif., Oct. 20, 2008

Oakley today announced its partnership with Augie’s Quest, the Muscular Dystrophy Association’s ALS research initiative, to develop two special edition Augie’s Quest HIJINX™ sunglasses benefiting the organization’s aggressive, cure-driven efforts to find treatments and cures for ALS.

ALS destroys the nerve cells controlling muscles, ultimately causing complete paralysis while leaving mental function intact. Survival is typically two to five years after diagnosis and no cure exists. With every sale of these special edition Augie’s Quest HIJINX™ sunglasses, Oakley will contribute US $20 to Augie’s Quest, creating a vision of hope in the fight against ALS.

“Augie has been a long time supporter of Oakley and we’re proud to team with him and Augie’s Quest,” said Scott Olivet, CEO, Oakley. “We honor Augie’s contributions to the fitness industry, his inspiration as an individual and entrepreneur, and the innovation he has brought to medical research and fundraising. For more than 30 years Oakley has made history, and with your help we will make history in the war against ALS.”

“I’m extremely grateful to Oakley for creating these special edition sunglasses,” said Augie Nieto, Founder and Chief Inspiration Officer, Augie’s Quest. “Not only do they combine great looks with the best sunglass technology, but they are also a fitting way to draw attention to the cause. Augie’s Quest is motivated by a bold vision of the day when the cure for ALS is found.”

The Augie’s Quest HIJINX sunglass from Oakley is available in two styles. The Polarized Augie’s Quest HIJINX eliminates 99% of glare with Oakley’s polarization technology. It also features a laser etched signature by Augie Nieto on the corner of the lens and on the inside stem, in addition to “Augie’s Quest” in script on the outside frame. The Non-Polarized Augie’s Quest HIJINX sunglass features a custom rendition of the Augie’s Quest logo laser etched on the corner of the lens, in addition to the outside frame and inside stem.